NVRO Profile
Nevro Corp., headquartered in Redwood City, California, is a leading medical device company specializing in advanced solutions for the management of chronic pain. Established in 2006, Nevro is recognized for its development and commercialization of innovative spinal cord stimulation (SCS) systems designed to improve the quality of life for patients suffering from severe, persistent pain. The company operates both domestically within the United States and internationally, reflecting its expansive reach in the medical device market.
The cornerstone of Nevro's product portfolio is the Senza spinal cord stimulation system, which is an evidence-based neuromodulation platform aimed at treating chronic pain. This system includes several advanced models, such as Senza II and Senza Omnia, each designed to deliver targeted, effective pain relief. The Senza system leverages the company's proprietary 10 kHz Therapy, a high-frequency stimulation technique that has been clinically validated to provide significant pain reduction without the use of traditional paresthesia (tingling sensation) associated with conventional SCS systems.
Nevro's approach to treating chronic pain is underpinned by a commitment to evidence-based solutions. The company’s 10 kHz Therapy is supported by extensive clinical research and real-world evidence demonstrating its efficacy in providing long-term relief for patients with chronic pain conditions. This focus on clinical evidence and patient outcomes underscores Nevro’s dedication to advancing neuromodulation technologies and enhancing treatment options for individuals struggling with debilitating pain.
The company employs a multi-faceted distribution strategy to reach its customers, utilizing a combination of direct sales teams, a network of independent sales agents, and third-party distributors. This comprehensive sales approach ensures broad accessibility and support for Nevro's products. As Nevro continues to expand its technological capabilities and global footprint, it remains focused on delivering cutting-edge pain management solutions that address the unmet needs of patients worldwide.
|